Healthful Plant-Based Diet May Lower Risk for Type 2 Diabetes
22 Jan 2024
Clinical Result
MONDAY, Jan. 22, 2024 -- A healthful plant-based diet may lower the risk for type 2 diabetes mellitus (T2DM), according to a study published in the January issue of Diabetes & Metabolism.
Alysha S. Thompson, from Queen's University Belfast in Northern Ireland, and colleagues examined associations between healthful and unhealthful plant-based diet indices (hPDI and uPDI) and T2DM using prospective data from the U.K. Biobank involving participants aged 40 to 69 years at baseline.
During 12 years of follow-up, 2,628 of the 113,097 study participants developed T2DM. The researchers found that compared with participants with the lowest hPDI scores (quartile 1), those with the highest scores (quartile 4) had a lower risk for T2DM (hazard ratio, 0.76). The association was mediated by lower body mass index (BMI) and lower waist circumference (proportion mediated, 28 percent for both), as well as lower concentrations of hemoglobin A1c, triglycerides, alanine aminotransferase, gamma glutamyl transferase, C-reactive protein, insulin-like growth factor 1, cystatin C, and urate (11, 9, 5, 4, 4, 4, 4, and 4 percent, respectively). There was an association seen between higher uPDI scores and higher T2DM risk (hazard ratio, 1.37), which was potentially mediated by higher waist circumference, BMI, and higher concentrations of triglycerides (17, 7, and 13 percent, respectively).
"Our findings suggest that high-quality plant-based diets, characterized by high consumption of fruits, vegetables, nuts, legumes, whole grains, tea and coffee, are beneficial for T2DM prevention, in line with existing dietary recommendations to increase plant food consumption to reduce T2DM risk," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Posted January 2024
More news resources
FDA Medwatch Drug Alerts
Daily MedNews
News for Health Professionals
New Drug Approvals
New Drug Applications
Drug Shortages
Clinical Trial Results
Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.